Endoscopic dilation of small-intestine strictures in Crohn's disease by balloon-assisted enteroscopy: a systematic review and meta-analysis
- PMID: 39568704
- PMCID: PMC11574157
- DOI: 10.20524/aog.2024.0920
Endoscopic dilation of small-intestine strictures in Crohn's disease by balloon-assisted enteroscopy: a systematic review and meta-analysis
Abstract
Background: Balloon-assisted enteroscopy (BAE) (both single- and double-balloon enteroscopy) has garnered attention in the treatment of small intestine strictures in patients with Crohn's disease (CD). This study aimed to evaluate the pooled clinical outcomes of BAE-mediated endoscopic dilation of small intestine strictures in patients with CD.
Methods: We searched multiple databases for articles reporting outcomes following BAE for small intestinal strictures in patients with CD. Outcomes studied were pooled technical success, clinical success and adverse events. Standard meta-analysis methods were employed using the random-effects model, and heterogeneity was studied using I 2 statistics.
Results: We analyzed 26 studies, 9 prospective and 17 retrospective, involving 1570 patients. The pooled technical success rate of double-balloon enteroscopy was 87.6% (95% confidence interval [CI] 82.1-91.5; I 2=53%) and the pooled therapeutic success rate was 69.7% (95%CI 61.6-76.7; I 2=71%). The pooled major complications per procedure were 5.5% (95%CI 3.5-8.4; I 2=57%); the risk of bleeding was 2.5% (95%CI 1.4-4.2; I 2=28%), and the risk of perforation was 2.7% (95%CI 1.6-4.5; I 2=3%). The pooled rate of recurrence after the first dilation was 42.3% (95%CI 16.9-72.5; I 2=59%), and the rate of repeat endoscopic balloon dilation was 23.9% (95%CI 14.1%-37.5%; I 2=85%), while the pooled rate of repeat surgery was 25.3% (95%CI 11.8%-46.0%; I 2=44%].
Conclusion: BAE is a good first line approach for patients with CD-induced strictures in an attempt to treat symptoms and potentially avoid surgery.
Keywords: Crohn’s disease; balloon-assisted enteroscopy; endoscopic dilation; stricture.
Copyright: © 2024 Hellenic Society of Gastroenterology.
Conflict of interest statement
Conflict of Interest: DGA: Consultant for Boston Scientific; all other authors declare no conflicts of interest.
Figures
References
-
- Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. - PubMed
-
- Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20–57. - PubMed
-
- Feuerstein JD, Cheifetz AS. Crohn disease:epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92:1088–1103. - PubMed
-
- Yano Y, Matsui T, Hirai F, et al. Cancer risk in Japanese Crohn's disease patients:investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–1305. - PubMed
LinkOut - more resources
Full Text Sources